Tag: Bedaquiline
Health Ministry approves introduction of new shorter treatment regimen for drug-resistant...
BPaLM regimen consisting of four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
TB Alliance applauds WHO’s rapid communication on key changes to treatment...
New guidelines have potential to transform the TB treatment landscape with six-month standard
“IMTECH’s translational science agenda holds a big promise”
Read the exclusive freewheeling interview with Dr Anil Koul, Director, CSIR-Institute of Microbial Technology-Chandigarh, where he shares his long term vision for the premier institute besides his insights on the required ingredients for the Indian innovation system. A Must Read......................
Govt clarifies on MDR-TB drug ‘Bedaquiline’ controversy
The union health ministry has clarified that the Bedaquiline which is used in selective cases, is available only through Revised National TB Control Programme (RNTCP) and open market sale of the drug is not permitted in India as of now...…………..
Mission Tuberculosis: Govt launches series of new combat initiatives
As per the health minister, Mr J P Nadda, the Indian government is committed to accelerate efforts to fight tuberculosis in the country